The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Is Cardiovascular Disease Slowing Improvements in Life Expectancy?: OECD and The King's Fund Workshop Proceedings
Abstract
Improvements in life expectancy at birth observed before the COVID-19 epidemic had slowed considerably in most OECD countries in recent years.Longevity gains fell on average 25%, when comparing the period between 2012 and 2017 to a decade earlier.One reason behind this is that cardiovascular disease (CVD) mortality improvements are now substantially lower than what they used to be in some countries.CVD is a major killer in OECD societies, causing many preventable deaths and large social inequalities.CVD mortality improvements recorded a reduction of over 50% in the United States, Italy, the Netherlands, Austria, Ireland, and Canada since 2010, relative to the prior decade.The same can be said for men in Portugal and women in Israel and Iceland.Several reasons underpin this trend.For a start, the prevalence of underlying lifestyle risk factors that cause CVD is rising.Rising trends in obesity and diabetes are estimated to offset the mortality reductions attributed to favourable changes in smoking.OECD estimates that overweight-related diseases will reduce life expectancy by nearly three years by 2050, without further policy action.Furthermore, newly emerging risk factors are contributing to higher CVD mortality, like drug overdose and air pollution.Severe influenza outbreaks in some recent winters, as in 2014-15, could also have impacted on CVD mortality, as influenza and pneumonia can trigger cardiovascular events like heart attacks, and in turn, individuals with CVD may be more susceptible to dying from influenza or pneumonia.The decelerating improvement in CVD mortality is a major cause for concern with implications for policy and research.First, these trends send a warning call for further action in primary prevention, early detection and secondary prevention.Health systems must better balance priorities between prevention -now accounting for less than 3% of total health spending -and treatment.Policies focussed on prevention that stimulate lifestyle changes need to be a priority universally, but health systems must also do better at delivering more cost-effective early detection and diagnosis.Some 40 to 72% of avoidable deaths are attributable to risk factors such as smoking, blood pressure and cholesterol levels, while 23 to 55% are linked to access to acute care and secondary prevention.Second, it remains urgent to address the large inequalities in CVD prevalence and mortality that penalise the most disadvantaged subgroups of the population.Reducing the unequal burden of CVD is likely to require a combination of targeted policies that go well beyond the health sector, such as housing, employment, and environmental policies, alongside strategies to improve diets, and reduce smoking and alcohol intake among these population groups.A move towards structural population-level prevention, such as fiscal and regulatory measures, can be effective and help to free resources to invest in other pressing areas, like the interface between health and social care.This would further help reduce inequalities, and tackle the pressures on health systems exerted by population ageing.Better understanding of which combination of strategies can offer the best overall approach for tackling the challenge of CVD in our populations over time is therefore an urgent research priority to support policy decisions.Third, there is a pressing need to improve the underpinning data and monitoring processes, making health data infrastructures more fit-for-purpose for understanding these trends.Data to support timely and effective monitoring of CVD mortality and morbidity is lacking, and the same applies for monitoring of risk 4 IS CARDIOVASCULAR DISEASE SLOWING IMPROVEMENTS IN LIFE EXPECTANCY? © OECD 2020factors for CVD such as overweight, blood pressure, smoking, air pollution, and drug abuse.More efforts must be made to optimise the use of existing data systems through linkage of epidemiological surveillance, clinical and administrative datasets, including primary and hospital care records, clinical data and death records.This will be particularly critical in the current COVID-19 epidemic where people with CVD are amongst the population subgroups with the highest mortality risk.The King's Fund and the OECD joined forces to raise awareness about the magnitude of these challenges and the need for an urgent policy response to address CVD mortality.This publication is the result of this collaboration.Based on discussions that took place in a joint workshop at OECD in Paris, it presents the evidence on trends in CVD mortality, and their contribution to the slowdown in improvements in life expectancy in some OECD countries.The workshop showed that there is still a long road to be travelled to better understand why we see these trends, and what action is needed to reverse them.Our hope is that this publication will help to shed some lights and support better policies in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600
Stanaway, J. D., Afshin, A., Gakidou, E., Lim, S. S., Abate, D., Abate, K. H., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32225-6 · Cited by 4,943
Health equity in England: the Marmot review 10 years on
Marmot, M. (2020) · BMJ · doi:10.1136/bmj.m693 · Cited by 1,834
European cardiovascular disease statistics
Allender, S. E., Scarborough, P., Peto, V., Rayner, M., Leal, J., Luengo-Fernández, R., & Gray, A. M. (2008) · Deakin Research Online (Deakin University) · Cited by 1,459
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Cardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care
OECD (2015) · OECD Health Policy Studies · doi:10.1787/9789264233010-en · Cited by 1,359
Self-citation(2019) · doi:10.1787/4dd50c09-en · Cited by 1,324
Projected effect of dietary salt reductions on future cardiovascular disease
Bibbins-Domingo, K., Chertow, G. M., Coxson, P. G., Moran, A., Lightwood, J. M., Pletcher, M. J., & Goldman, L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907355 · Cited by 1,253
Dicker, D., Nguyen, G., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31891-9 · Cited by 1,209
The Heavy Burden of Obesity: The Economics of Prevention
OECD (2019) · OECD Health Policy Studies · doi:10.1787/67450d67-en · Cited by 1,090
Self-citationKuulasmaa, K., Tunstall-Pedoe, H., Dobson, A., Fortmann, S., Sans, S., Tolonen, H., Evans, A., & Ferrario, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11180-2 · Cited by 952
What types of interventions generate inequalities? Evidence from systematic reviews
Lorenc, T., Petticrew, M., Welch, V., & Tugwell, P. (2013) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2012-201257 · Cited by 927
Decline in Cardiovascular Mortality: Possible Causes and Implications
Mensah, G. A., Wei, G. S., Sorlie, P. D., Fine, L. J., Rosenberg, Y., Kaufmann, P. G., Mussolino, M. E., Hsu, L. L., Addou, E., Engelgau, M. M., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309115 · Cited by 847
Unal, B., Critchley, J. A., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000118498.35499.b2 · Cited by 739
Dahlgren, G., & Whitehead, M. M. (1991) · RePEc: Research Papers in Economics · Cited by 710
Hunink, M. G. M. (1997) · JAMA · doi:10.1001/jama.277.7.535 · Cited by 679
Trends in life expectancy in EU and other OECD countries: Why are improvements slowing?
(2019) · OECD Health Working Papers · doi:10.1787/223159ab-en · Cited by 633
Moran, A. E., Forouzanfar, M. H., Roth, G. A., Mensah, G. A., Ezzati, M., Murray, C. J. L., & Naghavi, M. (2014) · Circulation · doi:10.1161/circulationaha.113.004042 · Cited by 575
Recent trends in cardiovascular mortality in the United States and public health goals.
Sidney, S., Quesenberry, C. P., Jaffe, M. G., Sorel, M., Nguyen-Huynh, M. N., Kushi, L. H., Go, A. S., & Rana, J. S. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1326 · Cited by 569
Puymirat, E., Simon, T., Cayla, G., Cottin, Y., Elbaz, M., Coste, P., Lemesle, G., Motreff, P., Popovic, B., Khalife, K., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.030798 · Cited by 539
Tunstall-Pedoe, H., Vanuzzo, D., Hobbs, M., Mähönen, M., Cepaitis, Z., Kuulasmaa, K., & Keil, U. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11181-4 · Cited by 514
Murray, C. J. L., Callender, C. S. K. H., Kulikoff, X. R., Srinivasan, V., Abate, D., Abate, K. H., Abay, S. M., Abbasi, N., Abbastabar, H., Abdela, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32278-5 · Cited by 484
Return on investment of public health interventions: a systematic review
Masters, R., Anwar, E., Collins, B., Cookson, R., & Capewell, S. (2017) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2016-208141 · Cited by 480
Recent trends in life expectancy across high income countries: retrospective observational study
Ho, J. Y., & Hendi, A. S. (2018) · BMJ · doi:10.1136/bmj.k2562 · Cited by 439
U.S. Health in International Perspective: Shorter Lives, Poorer Health
Institute of Medicine and National Research Council (2013) · National Academies Press eBooks · doi:10.17226/13497 · Cited by 323
Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999
Critchley, J., Liu, J., Zhao, D., Wei, W., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000140668.91896.ae · Cited by 304
Methamphetamine Use and Cardiovascular Disease: In Search of Answers
Kevil, C. G., Goeders, N. E., Woolard, M. D., Bhuiyan, M. S., Dominic, P., Kolluru, G. K., Arnold, C. L., Traylor, J. G., & Orr, A. W. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312461 · Cited by 294
Gaspoz, J.-M., Coxson, P. G., Goldman, P. A., Williams, L. W., Kuntz, K. M., Hunink, M. G. M., & Goldman, L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200206063462309 · Cited by 290
Nichols, M., Townsend, N., Scarborough, P., & Rayner, M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht159 · Cited by 289
Mortality in the United States, 2023
Murphy, S. L., Kochanek, K. D., Xu, J., & Arias, E. (2024) · doi:10.15620/cdc/170564 · Cited by 280
Tseng, Z. H., Olgin, J. E., Vittinghoff, E., Ursell, P. C., Kim, A. S., Sporer, K., Yeh, C., Colburn, B., Clark, N. M., Khan, R., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033427 · Cited by 277
Scarborough, P., Adhikari, V., Harrington, R. A., Elhussein, A., Briggs, A., Rayner, M., Adams, J., Cummins, S., Penney, T., & White, M. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003025 · Cited by 277
Steel, N., Ford, J. A., Newton, J. N., Davis, A. C. J., Vos, T., Naghavi, M., Glenn, S., Hughes, A., Dalton, A. M., Stockton, D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32207-4 · Cited by 258
Capewell, S., Beaglehole, R., Seddon, M., & McMurray, J. (2000) · Circulation · doi:10.1161/01.cir.102.13.1511 · Cited by 253
Cost-Effectiveness of Cholesterol-Lowering Therapies according to Selected Patient Characteristics
Prosser, L. A., Stinnett, A. A., Goldman, P. A., Williams, L. W., Hunink, M. G. M., Goldman, L., & Weinstein, M. C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-10-200005160-00002 · Cited by 249
Heart disease as a risk factor for dementia
Hakim, A., Ng, & Turek (2013) · Clinical Epidemiology · doi:10.2147/clep.s30621 · Cited by 229
Lewer, D., Jayatunga, W., Aldridge, R. W., Edge, C., Marmot, M., Story, A., & Hayward, A. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30219-1 · Cited by 223
Expected gains in life expectancy from various coronary heart disease risk factor modifications.
Tsevat, J., Weinstein, M. C., Williams, L. W., Tosteson, A. N., & Goldman, L. (1991) · Circulation · doi:10.1161/01.cir.83.4.1194 · Cited by 210
Bandosz, P., O'Flaherty, M., Drygas, W., Rutkowski, M., Koziarek, J., Wyrzykowski, B., Bennett, K., Zdrojewski, T., & Capewell, S. (2012) · BMJ · doi:10.1136/bmj.d8136 · Cited by 171
Reductions in sugar sales from soft drinks in the UK from 2015 to 2018
Bandy, L. K., Scarborough, P., Harrington, R. A., Rayner, M., & Jebb, S. A. (2020) · BMC Medicine · doi:10.1186/s12916-019-1477-4 · Cited by 167
Kadri, A. N., Wilner, B. R., Hernández, A. V., Nakhoul, G., Chahine, J., Griffin, B. P., Pettersson, G., Grimm, R. A., Navia, J. L., Gordon, S. M., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012969 · Cited by 162
Trends in Cardiometabolic Mortality in the United States, 1999-2017
Shah, N. S., Lloyd‐Jones, D. M., O’Flaherty, M., Capewell, S., Kershaw, K. N., Carnethon, M. R., & Khan, S. S. (2019) · JAMA · doi:10.1001/jama.2019.9161 · Cited by 161
Changes in dietary fat and declining coronary heart disease in Poland: population based study
Zatonski, W. A., & Willett, W. (2005) · BMJ · doi:10.1136/bmj.331.7510.187 · Cited by 158
Bajekal, M., Scholes, S., Love, H., Hawkins, N., O'Flaherty, M., Raine, R., & Capewell, S. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001237 · Cited by 158
Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004–14
Gabet, A., Danchin, N., Juillière, Y., & Olié, V. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx097 · Cited by 156
Rapid mortality falls after risk-factor changes in populations
Capewell, S., & O'Flaherty, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62302-1 · Cited by 149
Investigating the impact of the English health inequalities strategy: time trend analysis
Barr, B., Higgerson, J., & Whitehead, M. M. (2017) · BMJ · doi:10.1136/bmj.j3310 · Cited by 139
Trends in Substance Abuse Preceding Stroke Among Young Adults: A Population-Based Study
de los Ríos, F., Kleindorfer, D. O., Khoury, J., Broderick, J. P., Moomaw, C. J., Adeoye, O., Flaherty, M. L., Khatri, P., Woo, D., Alwell, K., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.667808 · Cited by 130
Shah, R. S., Wilkins, E., Nichols, M. S., Kelly, P., El-Sadi, F., Wright, F. L., & Townsend, N. P. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy378 · Cited by 129
Brown, T. J., Platt, S. D., & Amos, A. (2014) · European Journal of Public Health · doi:10.1093/eurpub/cku065 · Cited by 125
The Contemporary American Drug Overdose Epidemic in International Perspective
Ho, J. Y. (2019) · Population and Development Review · doi:10.1111/padr.12228 · Cited by 119
Pearson‐Stuttard, J., Bandosz, P., Rehm, C. D., Peñalvo, J. L., Whitsel, L. P., Gaziano, T., Conrad, Z., Wilde, P., Micha, R., Lloyd‐Williams, F., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002311 · Cited by 117
Health and Economic Benefits of Increased β-Blocker Use Following Myocardial Infarction
Phillips, K. A. (2000) · JAMA · doi:10.1001/jama.284.21.2748 · Cited by 112
National Trends in Patients Hospitalized for Stroke and Stroke Mortality in France, 2008 to 2014
Lecoffre, C., de Peretti, C., Gabet, A., Grimaud, O., Woimant, F., Giroud, M., Béjot, Y., & Olié, V. (2017) · Stroke · doi:10.1161/strokeaha.117.017640 · Cited by 107
Coronary heart disease policy models: a systematic review
Ünal, B., Capewell, S., & Critchley, J. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-213 · Cited by 97
Kypridemos, C., Allen, K., Hickey, G. L., Guzman-Castillo, M., Bandosz, P., Buchan, I. E., Capewell, S., & O’Flaherty, M. (2016) · BMJ · doi:10.1136/bmj.i2793 · Cited by 91
Cost-Effectiveness of Populationwide Educational Approaches to Reduce Serum Cholesterol Levels
Tosteson, A. N. A., Weinstein, M. C., Hunink, M. G. M., Mittleman, M. A., Williams, L. W., Goldman, P. A., & Goldman, L. (1997) · Circulation · doi:10.1161/01.cir.95.1.24 · Cited by 80
Goldman, L., Phillips, K. A., Coxson, P. G., Goldman, P. A., Williams, L. W., Hunink, M. G. M., & Weinstein, M. C. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01512-1 · Cited by 72
US Mortality in an International Context: Age Variations
Ho, J. Y., & Preston, S. H. (2010) · Population and Development Review · doi:10.1111/j.1728-4457.2010.00356.x · Cited by 72
Progress in reducing inequalities in cardiovascular disease mortality in Europe
Girolamo, C. D., Nusselder, W. J., Bopp, M., Brønnum‐Hansen, H., Costa, G., Kovács, K., Leinsalu, M., Martikainen, P., Pacelli, B., Valverde, J. R. R., et al. (2019) · Heart · doi:10.1136/heartjnl-2019-315129 · Cited by 63
Can dietary changes rapidly decrease cardiovascular mortality rates?
Capewell, S., & O’Flaherty, M. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr049 · Cited by 47
Menotti, A., Puddu, P. E., Kromhout, D., Kafatos, A., & Tolonen, H. K. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487318821250 · Cited by 47
The WHO International Classification of Diseases 11th Revision (ICD-11)
Dawson-Squibb, J.-J., Davids, E. L., Viljoen, M., Rice, K., & Stein, D. J. (2023) · Autism and child psychopathology series · doi:10.1007/978-3-031-24926-6_4 · Cited by 44
Changes in tobacco-related morbidity and mortality in French women: worrying trends
Olié, V., Pasquereau, A., Assogba, F. A. G., Arwidson, P., Nguyen‐Thanh, V., Chatignoux, É., Gabet, A., Delmas, M.-C., & Bonaldi, C. (2019) · European Journal of Public Health · doi:10.1093/eurpub/ckz171 · Cited by 36
A vision for population health: towards a healthier future
Buck, D., Baylis, A., Dougall, D., et al. (2018) · Cited by 32
Changing Trends in Mortality Decline during the Last Decades
Arriaga, E. E. (1995) · doi:10.1093/oso/9780198288824.003.0006 · Cited by 31
Wagner, A., Arveiler, D., Ruidavets, J. B., Bingham, A., Montaye, M., Ferrières, J., Dallongeville, J., Haas, B., & Ducimetière, P. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312452967 · Cited by 29
Bandosz, P., Ahmadi‐Abhari, S., Guzman-Castillo, M., Pearson‐Stuttard, J., Collins, B., Whittaker, H., Shipley, M. J., Capewell, S., Brunner, E. J., & O’Flaherty, M. (2019) · Diabetologia · doi:10.1007/s00125-019-05015-4 · Cited by 26
Mortality in Spain in the Context of the Economic Crisis and Austerity Policies
Regidor, E., Mateo‐Urdiales, A., Barrio, G., & de la Fuente, L. (2019) · American Journal of Public Health · doi:10.2105/ajph.2019.305075 · Cited by 22
Critchley, J., Capewell, S., O’Flaherty, M., Abu-Rmeileh, N. M. E., Rastam, S., Saidi, O., Sözmen, K., Shoaibi, A., Husseini, A. S., Fouad, F., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.031 · Cited by 19
Gabet, A., Chatignoux, É., Ducimetière, P., Danchin, N., & Olié, V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.194 · Cited by 17
Worrisome trends in the incidence of coronary artery disease events among young individuals
Salomaa, V. V. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319896051 · Cited by 9
Cited by
Health at a Glance 2023: OECD Indicators
OECD (2023) · Health at a Glance · doi:10.1787/7a7afb35-en · Cited by 808
Self-citationProgress Stalled? The Uncertain Future of Mortality in High‐Income Countries
Dowd, J. B., Polizzi, A., & Tilstra, A. M. (2025) · Population and Development Review · doi:10.1111/padr.12687 · Cited by 21
Metadata
- Authors
- OECD, & Fund, T. K.
- Venue
- OECD eBooks
- Publisher
- OECD Publishing
- Published
- 2020-05-19
- OpenAlex
- W4231860771
- Cited by
- 435
- References
- 73
- FWCI
- 184.69
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.